Page 18 - Topline News Today

Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update On track to report topline data from ACT-AD Phase 2 Alzheimers disease study in 2Q22 ... | March 24, 2022

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced Wednesday positive topline results from a Phase 3 study of etrasimod, an investigational, oral, once-a-day, selective sphingosine 1-phosphate

Study met primary endpoint, demonstrating noninferior total IgG reduction at day 29 with subcutaneously administered efgartigimod compared to intravenous (IV) administration Secondary endpoints show

FDA assessment concludes that the Phase II combination trial, LEGEND, may proceed The initiation of the trial is planned for H1 2022 and the publication of topline results is expected for H2 2023 ... | March 8, 2022

Study showed clinically meaningful impact on common symptoms of overactive bladder (OAB) compared to placebo from baseline to week 12 Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma

XARACOLL 300mg Dose Cohort Experienced Less Pain and XARACOLL was Generally Well Tolerated with an Adverse Event Profile Comparable to the Current Prescribing Information Innocoll Pharmaceuticals

The BiOLinkMatrix by HALLURA platform, a new smooth crosslinking method, is the next generation in Hyaluronic Acid (HA) Dermal Fillers offering more natural, safe and elastic-lifting solutions

Freds ImageMagick Scripts

Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome ... | February 10, 2022

- LYBALVI Demonstrated Less Weight Gain Compared to Olanzapine in Patients With Schizophrenia, Schizophreniform Disorder or Bipolar I Disorder - DUBLIN, Feb. 8, 2022 /PRNewswire/ -- Alkermes